Results 181 to 190 of about 84,389 (260)

Cephalosporin use and patient outcomes following removal of penicillin-cephalosporin cross-reactivity alerts from the electronic health record. [PDF]

Antimicrob Agents Chemother
Zimmer A, Zagari J, Sudnik P, Yamshchikov A, Lopa S, Spitznogle S, DePasquale W, Donnelly D, Dobrzynski D, Stern J, Shulder S, Quartuccio KS.   +11 more
europepmc   +1 more source

Molecular Functions and Drug Prediction of MMP1 and TGFBR2 in Nasopharyngeal Carcinoma

Journal of Clinical Laboratory Analysis, EarlyView.
MMP1 and TGFBR2 were validated by machine learning and external datasets as the candidate genes. Dexamethasone showed strong binding affinity to MMP1 (−7.72 kcal/mol) and TGFBR2 (−7.27 kcal/mol) in docking studies. Knockdown of MMP1 repressed the malignant phenotypes of NPC cells.
Feng Wang, Binbin Ge, Ming Li, Xiaochun Xia, Fuming Zhang, Pengqin Xu   +5 more
wiley   +1 more source

Discovery of Lomitapide as a Novel Mast Cell Regulatory Agent Through Chemical Library Screening. [PDF]

Eur J Immunol
Mamorita S, Furukawa A, Nagata Y, Suzuki R.   +3 more
europepmc   +1 more source

Extreme Heterophilic Antibody Interference in BNP Immunoassay: A Case Report and Systematic Investigation Protocol

Journal of Clinical Laboratory Analysis, EarlyView.
A 53 year‐old male with type 2 diabetes presented extremely elevated BNP (> 4000 pg/mL) but normal NT‐proBNP and cardiac function. Systematic verification confirmed severe heterophilic antibody (HAMA) interference in the BNP chemiluminescence immunoassay.
Huicong Yang, Yuanhai Zheng, Zhenhua Zeng, Haimin Gao, Jinzhi Wu, Ayang Wu, Jie Lin   +6 more
wiley   +1 more source

Nanoparticle-Based Targeted Drug Delivery Systems for Allergic Rhinitis: A Comprehensive Review. [PDF]

Int J Nanomedicine
Wang Y, Zhou Y, Liang B, Li S, Wang Z, Yan X, Gao Y, Li T, Qin Q, Yang S, Guo F, Nie J.   +11 more
europepmc   +1 more source

[Bronchial asthma and anti-allergic agents].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1993
openaire   +1 more source

Pseudohyperphosphatemia in Multiple Myeloma: A Systematic Review of Case Reports and Case Series

Journal of Clinical Laboratory Analysis, EarlyView.
Pseudohyperphosphatemia (PHP) is a clinically significant laboratory artifact in patients with multiple myeloma (MM). It is often caused by paraprotein interference with phosphate assays. This systematic review summarizes reported cases, underlying mechanisms, and diagnostic approaches to distinguish spurious from true hyperphosphatemia.
Mahsa Dabir, Maryam Kamrani Mousavi, Mohana Mohamadi, Ali Maleki   +3 more
wiley   +1 more source

AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes. [PDF]

Clin Exp Allergy
Zydron J, Balaji A, Chauhan J, Alder J, Chen X, Wiegman AMF, Poli A, Jacków-Malinowska J, Cheeseman J, Spencer DIR, McDonnell J, Spicer J, McCraw AJ, Karagiannis SN.   +13 more
europepmc   +1 more source

[Anti-allergic agent therapy of asthma].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1996
openaire   +1 more source

Improving Linkage to the HCV Care Cascade in Nonspecialist Settings: Evaluation of the Performance and Triage Utility of the Elecsys HCV Duo Assay in Japan

Journal of Clinical Laboratory Analysis, EarlyView.
In nonspecialist departments, most anti‐HCV–positive individuals do not proceed to RNA testing. The Elecsys HCV Duo assay simultaneously detects anti‐HCV antibodies and core antigen from a single blood draw and preferentially identifies patients with clinically meaningful viral loads.
Hiroko Setoyama, Takehisa Watanabe, Shiho Miyase, Masakuni Tateyama, Motohiko Tanaka, Nobuhiro Minami, Masato Sasaki, Shunpei Hashigo, Kotaro Fukubayashi, Shotaro Ishii, Mutsuo Koga, Ryo Ichikawa, Hirofumi Iwashita, Yoshinari Sakai, Toshihiko Motohara, Kohei Tomita, Akinori Nakata, Yutaka Kai, Takeyasu Kounoe, Katsuki Haraoka, Takako Inoue, Takanori Suzuki, Kentaro Matsuura, Yasuhito Tanaka   +23 more
wiley   +1 more source